CGS 27023A

CAS: 161314-82-5

Ref. 3D-LGA31482

Produktinformation

• Name: CGS 27023A
• Synonyme: Butanamide,N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl](3-pyridinylmethyl)amino]-3-methyl-,monohydrochloride, (2R)- (9CI), Cgs 27023, Cgs 27023A, Cona 60, Mmi 270, Mmi270B

Beschreibung

CGS 27023A is a monoclonal antibody that binds to the hydrophobic pocket of metalloproteases, leading to inhibition of their activity. This drug has been shown to have anti-inflammatory and matrix metalloproteinase inhibiting effects, which may be useful for the treatment of inflammatory diseases such as arthritis. CGS 27023A also inhibits angiogenesis and endothelial cell proliferation in vitro, which may be useful for the treatment of cancer. CGS 27023A has been shown to inhibit collagen-induced arthritis in mice.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 429.9 g/mol
• Formel: C₁₈H₂₄ClN₃O₅S
• Reinheit: Min. 95%